Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2 [PDF]
BMC Infectious Diseases, 2021 Background The outbreak of coronavirus disease 2019 (COVID-19) posed an enormous threat to public health. The use of antiviral drugs in patients with this disease have triggered people’s attentions.
Jingyuan Liu +7 more
doaj +2 more sources
Management of common autoimmune diseases in patients with myeloproliferative neoplasms treated with pegylated interferon alfa—case report, review of the literature and multidisciplinary clinical practice recommendations [PDF]
Therapeutic Advances in HematologyPegylated interferons alfa are increasingly used in patients with myeloproliferative neoplasms (MPN) due to their potential disease-modifying effect. Ropeginterferon alfa-2b has been approved for patients with polycythemia vera (PV) with no symptomatic ...
Axel Rüfer +7 more
doaj +2 more sources
Episcleritis in a patient with mucosal melanoma treated with interferon alfa-2b and radiotherapy: a case report [PDF]
Journal of Medical Case Reports, 2018 Background Mucosal melanoma of the head and neck is a rare malignant tumor associated with a poor prognosis. Surgery, chemotherapy, radiotherapy, and biotherapy are common strategies for treating mucosal melanoma of the head and neck.
Li Yang +3 more
doaj +2 more sources
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C [PDF]
New England Journal of Medicine, 1998 BACKGROUND Only 15 to 20 percent of patients with chronic hepatitis C have a sustained virologic response to interferon therapy. We compared the efficacy and safety of recombinant interferon alfa-2b alone with those of a combination of interferon alfa-2b
William M Lee
exaly +3 more sources
Interferon-alpha induced obsessivecompulsive disorder in a patient with Hepatitis-C
Psychiatry and Clinical Psychopharmacology, 2021 Interferon alpha (IFN- α) is commonly used in the treatment of viral hepatitis because of its stimulating effects on the immune response. While psychiatric adverse effects such as depression, mania or psychosis that arise during interferon alpha ...
Selma Bozkurt Zincir +3 more
doaj +1 more source
Baseline MELD score predicts hepatic decompensation during antiviral therapy in patients with chronic hepatitis C and advanced cirrhosis [PDF]
, 2013 Background and Aims: In patients with advanced liver cirrhosis due to chronic hepatitis C virus (HCV) infection antiviral therapy with peginterferon and ribavirin is feasible in selected cases only due to potentially life-threatening side effects ...
Dultz, Georg +11 more
core +12 more sources
Economic evaluation of first-line treatments for metastatic renal cell carcinoma: a cost-effectiveness analysis in a health resource-limited setting. [PDF]
PLoS ONE, 2012 BACKGROUND: To estimate, from the perspective of the Chinese healthcare system, the economic outcomes of five different first-line strategies among patients with metastatic renal cell carcinoma (mRCC).
Bin Wu +6 more
doaj +1 more source
Interferon-alfa in the management of cystic craniopharyngioma in children under 5 years of age
Archives of Pediatric Neurosurgery, 2021 Introduction: the best therapeutic option for the management of craniopharyngioma in younger children remains controversial, ranging from complete surgical resection, partial surgical resection associated with radiotherapy and application of ...
Jose Roberto Tude Melo +3 more
doaj +1 more source
Importance of adherence for efficacy of hepatitis C combined therapy [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2013 Introduction. Dual antiviral therapy with pegylated interferon alfa-2a and ribavirin leads do sustained elimination of hepatitis C virus infection in over 50% patients with genotypes 1 and 4 and in over 80% with genotypes 2 and 3.
Nožić Darko +5 more
doaj +1 more source